Greenpharm: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Greenpharm
Largest movements
- Cash -€3,218
down €3,218 (-3.6%), from €88,416 to €85,198
mainly Net result for the year (-€2,822) and Trade debts (-€396)
- Profit (loss) carried forward -€2,822
down €2,822 (-8.4%), from -€33,706 to -€36,528
- Gross operating margin +€478
up €478 (+16.6%), from -€2,870 to -€2,392
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €88,416 | €85,198 | -€3,218 | -3.6% |
| Current assets | 29/58 | €88,416 | €85,198 | -€3,218 | -3.6% |
| Cash at bank and in hand | 54/58 | €88,416 | €85,198 | -€3,218 | -3.6% |
| Total equity and liabilities | 10/49 | €88,416 | €85,198 | -€3,218 | -3.6% |
| Equity | 10/15 | €56,362 | €53,539 | -€2,822 | -5.0% |
| Contributions | 10/11 | €90,067 | €90,067 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€33,706 | -€36,528 | -€2,822 | -8.4% |
| Amounts payable | 17/49 | €32,054 | €31,658 | -€396 | -1.2% |
| Amounts payable within one year | 42/48 | €32,054 | €31,658 | -€396 | -1.2% |
| Trade debts | 44 | €2,396 | €2,000 | -€396 | -16.5% |
| Suppliers | 440/4 | €2,396 | €2,000 | -€396 | -16.5% |
| Other amounts payable | 47/48 | €29,658 | €29,658 | = | 0.0% |
| Other operating charges | 640/8 | €396 | €400 | +€4 | +0.9% |
| Gross operating margin | 9900 | -€2,870 | -€2,392 | +€478 | +16.6% |
| Operating profit (loss) | 9901 | -€3,266 | -€2,792 | +€474 | +14.5% |
| Financial charges | 65/66B | €30 | €30 | = | 0.0% |
| Recurring financial charges | 65 | €30 | €30 | = | 0.0% |
| Profit (loss) for the period before taxes | 9903 | -€3,296 | -€2,822 | +€474 | +14.4% |
| Profit (loss) for the period | 9904 | -€3,296 | -€2,822 | +€474 | +14.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€3,296 | -€2,822 | +€474 | +14.4% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 1 October 2026 via checked.be.